TITLE

GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs

AUTHOR(S)
Jarman, Paul R.; Bandmann, O.; Marsden, C. D.; Wood, N. W.; Jarman, P R
PUB. DATE
September 1997
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep1997, Vol. 63 Issue 3, p304
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66329252

 

Related Articles

  • CASE 2 DIAGNOSIS: DOPA-RESPONSIVE DYSTONIA DUE TO GTP CYCLOHYDROLASE 1 DEFICIENCY. Carter, Melissa T.; Fehlings, Darcy // Paediatrics & Child Health (1205-7088);Dec2012, Vol. 17 Issue 10, p570 

    The article presents the case study of a patient with symptoms of dopa-responsive dystonia (DRD) caused by deficiency GTP cyclohydrolase 1. Medical screening of the patient showed brisk deep-tendon teflexes in the legs, which can be mistaken for a positive Babinski sign. Dystonia without...

  • Novel mutation in a patient with Dopamine Responsive Dystonia with severe dyskinesia. Sidle, K.; Wood, Nicholas; Warner, Graham; Marion, Marie-Helen // Annals of Indian Academy of Neurology;2007 Supplement 2, Vol. 10, p44 

    Dopamine responsive dystonia (DRD) is an autosomal dominant condition due, most commonly, to mutations within the GTP cyclohydrolase enzyme resulting in deficient dopamine production. Typically, patients present with features of parkinsonism with symptoms worse towards the end of the day...

  • Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Clot, Fabienne; Grabli, David; Cazeneuve, Cécile; Roze, Emmanuel; Castelnau, Pierre; Chabrol, Brigitte; Landrieu, Pierre; Nguyen, Karine; Ponsot, Gérard; Abada, Myriem; Doummar, Diane; Damier, Philippe; Gil, Roger; Thobois, Stéphane; Ward, Alana J.; Hutchinson, Michael; Toutain, Annick; Picard, Fabienne; Camuzat, Agnès; Fedirko, Estelle // Brain: A Journal of Neurology;Jul2009, Vol. 132 Issue 7, p1753 

    Dopa-responsive dystonia is a childhood-onset dystonic disorder, characterized by a dramatic response to low dose of l-Dopa. Dopa-responsive dystonia is mostly caused by autosomal dominant mutations in the GCH1 gene (GTP cyclohydrolase1) and more rarely by autosomal recessive mutations in the TH...

  • Guanine Triphosphate—Cyclohydrolase 1—Deficient Dopa-Responsive Dystonia Presenting as Frequent Falling in 2 Children. Tsao, Chang-Yong // Journal of Child Neurology;Mar2012, Vol. 27 Issue 3, p389 

    Guanine triphosphate (GTP)–cyclohydrolase 1 (GCH1)–deficient dopa-responsive dystonia is caused by GCH1 gene mutation. Two children presenting with frequent daily falling are reported with GCH1 gene mutations with persistent response to low-dose levodopa/carbidopa. Typical and...

  • Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers. Mencacci, Niccolò E.; Isaias, Ioannis U.; Reich, Martin M.; Ganos, Christos; Plagnol, Vincent; Polke, James M.; Bras, Jose; Hersheson, Joshua; Stamelou, Maria; Pittman, Alan M.; Noyce, Alastair J.; Mok, Kin Y.; Opladen, Thomas; Kunstmann, Erdmute; Hodecker, Sybille; Münchau, Alexander; Volkmann, Jens; Samnick, Samuel; Sidle, Katie; Nanji, Tina // Brain: A Journal of Neurology;Sep2014, Vol. 137 Issue 9, p2480 

    Mutations in the gene encoding the dopamine-synthetic enzyme GTP cyclohydrolase-1 (GCH1) cause DOPA-responsive dystonia (DRD). Mencacci et al. demonstrate that GCH1 variants are associated with an increased risk of Parkinson's disease in both DRD pedigrees and in patients with Parkinson's...

  • GTP Cyclohydrolase I and Tyrosine Hydroxylase Gene Mutations in Familial and Sporadic Dopa-Responsive Dystonia Patients. Cai, Chunyou; Shi, Wentao; Zeng, Zheng; Zhang, Meiyun; Ling, Chao; Chen, Lei; Cai, Chunquan; Zhang, Benshu; Li, Wei-Dong // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Dopa-responsive dystonia (DRD) is a rare inherited dystonia that responds very well to levodopa treatment. Genetic mutations of GTP cyclohydrolase I (GCH1) or tyrosine hydroxylase (TH) are disease-causing mutations in DRD. To evaluate the genotype-phenotype correlations and diagnostic values of...

  • Mutations in the gene encoding ε-sarcoglycan cause myoclonus?dystonia syndrome. Zimprich, Alexander; Grabowski, Monika; Asmus, Friedrich; Naumann, Markus; Berg, Daniela; Bertram, Markus; Scheidtmann, Karl; Kern, Peter; Winkelmann, Juliane; Müller-Myhsok, Bertram; Riedel, Leonhard; Bauer, Matthias; Müller, Tanja; Castro, Mirna; Meitinger, Thomas; Strom, Tim M.; Gasser, Thomas // Nature Genetics;Sep2001, Vol. 29 Issue 1, p66 

    The dystonias are a common clinically and genetically heterogeneous group of movement disorders. More than ten loci for inherited forms of dystonia have been mapped, but only three mutated genes have been identified so far. These are DYT1, encoding torsin A and mutant in the early-onset...

  • Two in the hand, an essential lesson in tremor management. Gallagher, Paul; Archibald, Neil; Paul Goldsmith; David Burn // Practical Neurology (BMJ Publishing Group);Jun2010, Vol. 10 Issue 3, p8 

    Dopa responsive dystonia results from abnormalities in the dopamine synthesis pathway which produces an array of phenotypic presentations with equally numerous genotypes. First documented in children in 1971, the 'classic' phenotype is childhood onset, predominantly lower limb dystonia which...

  • Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. Van Hove, J. L. K.; Steyaert, J.; Matthijs, G.; Legius, E.; Theys, P.; Wevers, R.; Romstad, A.; Møller, L. B.; Hedrich, K.; Goriounov, D.; Blau, N.; Klein, C.; Casaer, P. // Journal of Neurology, Neurosurgery & Psychiatry;Jan2006, Vol. 77 Issue 1, p18 

    Background: Segawa syndrome due to GIP cyclohydrolase deficiency is an autosomal dominant disorder with variable expression, that is clinically characterised by L-dopa responsive, diurnally fluctuating dystonia and parkinsonian symptoms. Objective: To delineate the neurological and psychiatric...

  • Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD). De Rosa, Anna; Carducci, Claudia; Carducci, Carla; Peluso, Silvio; Lieto, Maria; Mazzella, Andrea; Saccà, Francesco; Brescia Morra, Vincenzo; Pappatà, Sabina; Leuzzi, Vincenzo; De Michele, Giuseppe // Journal of Neurology;Nov2014, Vol. 261 Issue 11, p2204 

    The clinical diagnosis of Parkinson's Disease (PD) is not supported by Single Photon Emission Computed Tomography (SPECT) using dopamine transporter radioligand in 4-15 % of patients. It has been hypothesized that this phenomenon, named 'Scans Without Evidence of Dopaminergic Deficiency'...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics